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Agreement between ophthalmoscopy and photography was
not substantially altered by the status of the pupils, as is
evident from the figures of 107 eyes (62,2%) and 98 eyes
(56,9%) before and after dilatation, respectively. However, the
detection rate for retinopathy by ophthalmoscopy through
dilated pupils was only 64,7% of that of the camera. This is in
line with the results reponed by others.5•7
In 37 eyes (21,5%) diabetic retinopathy that could not be
substantiated from the photographs was detected by ophthalmo-
scopy through dIlated pupils. It is possible that the lesions
observed fell outside the field of photography, although they
were documented to be confined to the posterior pole of the
retina. Although we are of the opinion that diabetic retinopathy
was grossly overdiagnosed by ophthalmoscopy after dilatation
of the pupils, these patients must still be referred for full
ophthalmological assessment.
Rosen et al. 11 found it difficult for patients to follow both
the external and the internal fixation lamps of the non-
mydriatic camera, a problem that we did not encounter with
the CR445NM camera. The same authors also criticised non-
mydriatic fundus photography on the grounds that it did
not detect peripheral retinal ischaemia, peripheral intraretinal
micro-angiopathy, or even macular oedema. However, the
same applies to most other fundus cameras when fluorescein
angiography is not performed:
In conclusion, we found the CR4-45NM camera easy to
operate and no photographs were lost due to malfunction. We
also found photography through a dilated pupil to be superior
to non-mydriatic fundus photography. The camera proved
itself valuable in conjunction with ophthalmoscopy as a means
of screening for diabetic retinopathy under our clinic circum-
stances. In addition to providing permanent records of a
patient's retina, the camera also provides excellent material for
student education.
We are indebted to Mr R. Taylor for taking the photographs
and to the Staff and patients of the diabetic clinic for their co-
operation.
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Results of laser treatment for sub-retinal
neovascular membranes
M. J. N. CARTER, A. A. STULTING
Summary
A retrospective study was carried out to determine the results
of laser treatment for choroidal neovascular membranes in
age-related macular degeneration in 92 patients in whom
fluorescein angiography was performed for this condition
over a 7-year period. Twenty-nine of these patients, treated
with the argon laser, were followed up regularly for 15 months.
The treatment comprised overlapping laser spots of 200 J.Lm
and an average power of 390 mW. The results of this study
demonstrated that: (i) the majority of membranes were closer
·than 500 J.Lm from the foveola; (ii) the second eye involvement
rate in the same patient was 15,79% over 15 months; and (iii)
a 37,5% significant visual' loss or 41% two lines or greater
visual loss was seen after 15 months, which compares
favourably with results of laser treatment reported by other
institutions.
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Age-related macular degeneration with subsequent neovascular
membrane formation is a major cause of blindness in patients
in the 6th and 7th decades of life.
Neovascularisation results from invasion of the sub-retinal
pigment epithelial space by vessels originating in the chorio-
capillaris. I•2 The new vessels grow under the retinal pigment
epithelium through breaks caused by degenerative changes in
Bruch's membrane. 2 It has been suggested that the neovascular
membrane may cause the break and not vice versa. 3
Symptoms occur when the macula is affected by serous or
haemonhagic detachment of the retinal pigment epithelium
and sensory· retina produced by exudation from these new
vessels. I-l This exudative and sometimes haemorrhagic process
often leads to severe and permanent loss of central vision
because of sub-retinal fibrovascular organisation.2 Progressive
functional deterioration has been reponed in the natural course
of neovascular membranes. The Macular Photocoagulation
Study Group in the USA has demonstrated the definite
benefits of laser photocoagulation in the treatment of choroidal
neovascular membranes and has advised treatment of choroidal
new vessels located 200 J.Lm or more from the centre of the
foveal avascular zone.3-7 In their study, severe visual loss was
postponed for ,18 months.
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Subjects and methods
A retrospective study reviewed 92 patients in whom fluores-
cein angiography was performed for suspected choroidal neo-
vascular membranes and their subsequent clinical course from
1981 to 1988.
Of the 92 cases of fluorescein angiography performed, 29
demonstrated treatable choroidal neovascular membranes and
63 either untreatable membranes or other diagnoses.
The average age of the 63 untreated patients was 66,74 years
and the male to female ratio 39':24. Fig. 1 shows the ratio of
right to left eyes and the visual acuity at presentation.
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Treatment
All patients were treated with argon photocoagulation with
an average power of 390 mW. Low intensity, longer duration
spotS are advised to avoid haemorrhage. 2 The spot size was
400 ).Lm except for 2 patients who were treated with 100 ).Lm.
The intention was to overlap the shots, although, on reviewing
the angiograms, some turned out to be in a grid panern.
If the number of shots is compared with the size of the
neovascular membranes, the range was found to be 19,3 shots
for a neovascular membrane of y. disc diameter; 33,4 shots at
~ disc diameter; 43,6 shots at ~ disc diameter; 55,6 shots at 1
disc diameter and 60 shots at 2 disc diameters.
The size of the neovascular membane was measured in
relation to the disc diameter 2 minutes after injection of
fluorescein. The size of membrane did not correlate with the
amount of visual loss. The patient was considered treated if
the retina remained flat, an atrophic scar formed or no dye
leakage occurred.2
The majority of membranes were either directly supetior or
inferior to the foveola.
As regards the distance from the foveola to change in visual
acuity, the visual acuity outcome is reE0rted to be worse when
the membrane is closer to the foveola. ,8
The following observations were made: the majority of
membranes were closer than 500 ).Lm from the foveola, probably
because the symptoms were noticed earlier. Figs 2-4 illustrate
the visual acuity before laser treatment and after 15 months,
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Fig. 3. Less than 1 000 JLm from foveola - pre-operatively to 15
months postoperatively(~= visual acuity pre-operatively; _
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Fig. 2. Less than 500 JLm from foveola - pre-operatively to 15
months postoperatively (~= visual acuity pre-operatively; _




Indications for fluorescein angiography
Of the 63 patients, 42 had a choroidal neovascular membrane
in one eye and symptoms or signs on the opposite side. The
pathological conditions found in the other 21 untreated patients
included haemorrhages, angioid streaks, retinal pigment
epithelium detachment in age-related macular degeneration,
lacquer cracks and sub-retinal pigment epithelium
haemorrhage.
The reasons for which no treatment was carried out included
sub-foveal neovascular membranes in 56 eyes and other diag-
noses in 70 eyes.
Results
Fig. 1. Untreated patients(~= R eyes; _ = L eyes).
Twenty-nine patients were treated with laser photocoagulation
and followed up at regular intervals for a minimum of 15
months. Their ages ranged from 42 years to 80 years (average
age 68,51 years). The ratio of right to left eye involvement was
13:16 and the male to female ratio was 11:18. As reported in
the clinical notes, the macular appearance was as follows:
normal (6,89%); oedema (10,34%); haemorrhage (17,24%); scar
tissue (6,89%); dirty grey membrane as the only feature (6,89%);
drusen (27,58%); cystoid macular oedema (6,89%); and retinal
pigment epithelium detachment (17,24%).
Eighty per cent of patients with membranes had age-related
macular degeneration and 20% had other diagnoses.
Patients with symptoms or signs of a neovascular membrane
had fluorescein angiography performed and developed and
treatment, if necessary, within the space of one morning.
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Fig. 4. Greater than 1 000 j.lm from foveola - pre-operatively to
15 months postoperatlvely (~= visual acuity pre-operatively;
_ = visual acuity 15 months after treatment).
The changing visual acuity in the treated eyes, which were
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Fig. 8. Visual acuity - 6 months.
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Fig. 9. Visual acuity - 15 months.
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Fig. 6. Visual acuity - 1 month.
Fig. 10 summarises the visual acuity before laser treatment
to that at 15 months, with a reasonable number of patients
retaining useful vision.
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Fig. 12. Visual loss: < 201100: > 20/100, excluding 5 patients
with < 20/100 initial visual acuity (~= visual acuity better
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Fig. 10. Visual acuity pre-operatively to 15 months postoperatively
(6TITII = visual acuity pre-operatively; _ = visual acuity post-
operatively).
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Fig. 11. Visual loss: < 201100: > 201100 (~= visual acuity
better than 201100; _ = visual acuity worse than 201100).
Fig. 11 shows visual loss at > 20/100 to < 20/100 visual
acuity.
In Fig. 12 the 5 patients with < 20/100 visual acuity at
initial examination ate excluded.
If the 10 eyes which were already involved at initial examina-
tion are excluded, the second eye involvement rate was 15,79%
over 15 months. This illustrates the importance of an Amsler
grid, although according to published reports, only 10% of
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patients admit that changes in the grid panern are the first
visual symptoms noted. Ninety per cent of our patients noted
changes when confronted with an Amsler grid.
In conclusion, the Macular Photocoagulation Study Group
in the USA examined untreated and treated eyes with well-
defmed neovascular membranes ~ 200 J.Lm from the centre of
the foveal avascular zone and the results showed conclusively
that laser photocoagulation was beneficial in reducing the risk
of severe visual loss from sub-retinal neovascular membranes
associated with age-related macular degeneration by 51%after
1 year to 24% after 3 yearsY Our study showed a 37,5%
significant visual loss or a 41% ~ two lines loss after 15
months.
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